Sun Pharmaceutical Industries Limited announced that the Board of Directors of the company at its meeting held on January 31, 2022 accepted the resignation of Mr. Sunil Ajmera as the Company Secretary and Compliance officer of the company with effect from close of business hours on January 31, 2022. As per the resignation letter of Mr. Sunil Ajmera, his resignation was due to change in his role and responsibilities within the organization. Appointed Mr. Anoop Deshpande as the Company Secretary and Compliance Officer of the Company w.e.f. close of business hours on January 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,430 INR | -1.60% | -2.39% | +13.53% |
05-27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
05-25 | Sun Pharma to Pursue M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.53% | 41.95B | |
+22.20% | 22.53B | |
+17.35% | 14.11B | |
+45.62% | 12.5B | |
-0.05% | 6.79B | |
-9.44% | 6.75B | |
-8.87% | 5.73B | |
+14.55% | 5.6B | |
+4.00% | 4.95B | |
+18.64% | 4.38B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Announces Change of Company Secretary and Compliance Officer